NewsRx

Search our medical news database

Clinical Trials Week

Susan Hasty, Publisher

Table of Contents . . . December 8th, 2003

Non-Subscriber - Summaries Only

Related Areas: Other Issues in Clinical Trials Week | Other Publications

Clinical Trials - Challenges of recruitment and retention in multisite clinical research

Heart Attack - TP10 complement inhibitor decreases heart attacks, death

Atrial Fibrillation - Positive phase II selodenoson data presented

Oncology Trials - Clinical trials in pediatric cancer: Parental perspectives on informed consent

Reproductive Medicine - Nitric oxide donors don't improve cervical ripening before induced abortion

Aging - Testosterone research strategies outlined by IOM

Allergy - Astelin effective in patients whose allergies respond inadequately to Allegra

Angina - Blood-thinning agent may be better than heparin

Angina - Significant benefits of TMR demonstrated over drug therapy

Asthma - Long-term Aerospan treatment has no effect on growth in mildly asthmatic children

Atherosclerosis - Lipitor reduces progression of atherosclerosis in new study

Atrial Fibrillation - Arctic Circler highlighted at heart association meeting

Attention Deficit Hyperactivity Disorder - Girls lack of hyperactivity may lead to under-diagnosis

Blood Cancer - Data presented on Revimid in malignant blood disorders

Brain Cancer - AP23573 potently blocks brain tumor cell growth

Breast Cancer - Imaging technique may enable diagnosis without biopsy

Cancer Care - Partnership provides leading-edge care to under-served Los Angeles residents

Cancer Therapy - CCI-779 prevents abnormal brain cell growth and reverses seizures in lab mice

Cardiovascular Disease - Cholesterol in skin helps identify hidden cardiovascular disease

Colon Cancer - Modified de Gramont with oxaliplatin in treatment of advanced colorectal cancer

Congestive Heart Failure - First implantation of unique cardioverter defibrillator reported

Congestive Heart Failure - Positive phase II trial results reported on Adentri

Coronary Artery Bypass - Results of phase III PRIMO-CABG trial presented

Coronary Artery Disease - Details on third CardioPass patient released, phase II trials started

Coronary Artery Disease - Landmark trial in coronary atherosclerosis concluded

Corporate Update - Antipathogen company moves toward clinical trials, engages GunnAllen Financial

Drug Delivery - Dosing completed in phase III trials of Metformin, Ciprofloxacin

Drug Delivery - Trial demonstrates successful delivery of obesity drug nasal spray

Drug Review - FDA's fast track initiative cut development time by 3 years

Finance - Immune disorders drug maker reports loss of $0.01 per share

Finance - Prestara maker reports increased losses, decreased revenues, in third quarter

Glomerulonephritis - CYC202 has beneficial effects in kidney disease models

Glucose Control - Exenatide continues to generate positive results in second phase III study

Head and Neck Cancer - Advanced head and neck cancer drug being evaluated in phase I trial

Heart Attack - Antiplatelet drug found to reduce risk of recurrent heart attacks, stroke

Heart Attack - Drug proven to benefit heart attack victims is vastly underused

Heart Attack - Trial to evaluate TNKase/Metalyse use prior to angioplasty

Heart Disease - Cilostazol reduces coronary artery stent restenosis by 40%

Heart Pumps - Site selection nears completion for trial of DeBakey VAD for destination therapy

Hematology - Single agent thalidomide won't help those with relapsed acute myeloid leukemia

Hepatitis C VIrus - Safety trial initiated for experimental hepatitis C drug treatment

Inflammation - Pathway found implicating superoxide as important mediator of inflammatory pain

Insomnia - FDA extends PDUFA action date for Estorra NDA

Insulin Research - Company to reacquire rights and data from alliance on modified insulin products

Japanese Encephalitis - Chimeric attenuated vaccine protects against Japanese encephalitis

Kidney Disease - Research program to study effects of D-Receptor activation

Leukemia - Positive Dacogen data presented at chemotherapy conference

Leukemia Therapy - In AML patients, pretransplant MRD status predicts auto-SCT outcome

Limb Ischemia - Data reported from gene therapy using engineered form of the HIF-1alpha

Lung Cancer - Weekly carboplatin and paclitaxel in elderly non-small cell lung cancer patients

Macular Degeneration - New anecortave acetate clinical trials initiated

Market Analysis - Clinical trial communication plans can be helped with toolkit

Melanoma - Genasense may improve activity of anticancer therapy

Myocardial Infarction - Study: Newer formulation of heparin improves outcomes

Non-Hodgkin Lymphoma - Phase III trial of Rituxan maintenance reaches efficacy endpoint early

Obesity Therapy - Oxyntomodulin suppresses appetite and reduces food intake in humans

Otitis Media - 7-Valent pneumococcal conjugate vaccine effective against otitis media

Ovarian Cancer - A phase II trial of bryostatin-I in recurrent epithelial ovarian carcinoma

Pain Therapy - Approval granted for phase II trial of AeroLEF

Patents - Patent office allows additional patent claims to STR for cancer therapy

Postoperative Ileus - Enrollment completed in phase III study 308 of Entereg

Premature Birth - U.S. study initiated in pregnant women at high risk of preterm delivery

Prostate Cancer - Improving quality of life in men with prostate cancer

Prostate Cancer - Phase III trial of Acapodene initiated for the treatment of androgen deprivation

Prostate Cancer - Pivotal Eligard 45-mg phase III clinical study

Prostate Cancer - Provenge phase III data shows extended survival time

Pulmonary Arterial Hypertension - Pulmonary arterial hypertension treatment data shows prolonged survival

Renal Disease - At-home dialysis an effective option for more patients

Rheumatoid Arthritis - Phase IIb clinical trials of Pralnacasan discontinued due to toxicity

Rheumatoid Arthritis - Positive data reported on rheumatoid arthritis treatment study

Thoracic Aneurysms - Talent Thoracic Stent Graft study begins

Translational Research - New strategy aims to make U.K. bioscience sector a world beater

Uveitis - Drug delivery technology for ophthalmology applications presented

Vertebral Compression Fractures - FDA grants investigational device exemption for bone void filler clinical study

Wound Healing - Study results indicate Oasis may be "more likely to heal"

Return to Top of Page

NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook